Payment overview · 2025
General Payments
$180.54
8 reported records · 4 companies
Healthcare provider profile · identity verified
John Kit Wang, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · NEW YORK, NY · NPI 1124125703
Verified facts
What the public records show
CMS Open Payments records show John Kit Wang, M.D. received $180.54 in general payments during 2025 across 8 reported records.
ABBVIE INC. accounted for 57.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 8 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Creon, Synthroid, Trelegy Ellipta.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported RINVOQ as an associated drug or biological on 279238 records involving 34343 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Rinvoq by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 107 claims for Synthroid by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 279 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $104.28 | 57.8% | 4 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $44.95 | 24.9% | 2 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $15.93 | 8.8% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $15.38 | 8.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $180.54 | 8 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CREON Normalized: creon |
Drug | ABBVIE INC. | $49.36 | 2 | 2025 |
Source payment records
|
|||||
| LINZESS Normalized: linzess |
Drug | ABBVIE INC. | $49.36 | 2 | 2025 |
Source payment records
|
|||||
| VERQUVO Normalized: verquvo |
Drug | Merck Sharp & Dohme LLC | $44.95 | 2 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $33.64 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $33.64 | 1 | 2025 |
Source payment records
|
|||||
| SYNTHROID Normalized: synthroid |
Drug | ABBVIE INC. | $21.28 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $15.93 | 1 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $15.38 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| CREON creon |
2025 | Creon | 2024 | 28 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| SYNTHROID synthroid |
2025 | Synthroid | 2024 | 107 | exact normalized | Medicare Part D |
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 279 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
28 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | RINVOQ open payments reported associated product |
CMS Open Payments — General Payments 279238 supporting records · 34343 recipient NPIs · example record 1201352600 |
Rinvoq · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
107 | 28 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
279 | 55 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1343 | 397 |
| Amlodipine Besylate | Amlodipine Besylate | 769 | 213 |
| Levothyroxine Sodium | Levothyroxine Sodium | 526 | 142 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 525 | 158 |
| Omeprazole | Omeprazole | 478 | 143 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 395 | 96 |
| Zolpidem Tartrate | Zolpidem Tartrate | 392 | 81 |
| Metformin Hcl | Metformin Hcl | 360 | 110 |
| Gabapentin | Gabapentin | 317 | 80 |
| Eliquis | Apixaban | 300 | 61 |
| Metoprolol Succinate | Metoprolol Succinate | 291 | 91 |
| Losartan Potassium | Losartan Potassium | 288 | 89 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 279 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 253 | 74 |
| Azithromycin | Azithromycin | 219 | 154 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 185 | 60 |
| Finasteride | Finasteride | 184 | 56 |
| Lisinopril | Lisinopril | 172 | 51 |
| Montelukast Sodium | Montelukast Sodium | 170 | 42 |
| Alprazolam | Alprazolam | 162 | 48 |
| Ezetimibe | Ezetimibe | 159 | 53 |
| Escitalopram Oxalate | Escitalopram Oxalate | 155 | 52 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 151 | 58 |
| Jardiance | Empagliflozin | 149 | 37 |
| Diclofenac Sodium | Diclofenac Sodium | 140 | 54 |
| Clonazepam | Clonazepam | 136 | 45 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 128 | 42 |
| Ammonium Lactate | Ammonium Lactate | 125 | 21 |
| Famotidine | Famotidine | 123 | 37 |
| Clopidogrel | Clopidogrel Bisulfate | 122 | 38 |
| Prednisone | Prednisone | 122 | 42 |
| Allopurinol | Allopurinol | 121 | 32 |
| Trazodone Hcl | Trazodone Hcl | 120 | 37 |
| Fluticasone Propionate | Fluticasone Propionate | 116 | 35 |
| Hydrochlorothiazide | Hydrochlorothiazide | 116 | 37 |
| Januvia | Sitagliptin Phosphate | 112 | 23 |
| Baclofen | Baclofen | 111 | 55 |
| Pantoprazole Sodium | Pantoprazole Sodium | 110 | 28 |
| Synthroid | Levothyroxine Sodium | 107 | 28 |
| Meloxicam | Meloxicam | 93 | 37 |
| Valsartan | Valsartan | 92 | 30 |
| Tradjenta | Linagliptin | 91 | 16 |
| Furosemide | Furosemide | 90 | 28 |
| Valacyclovir | Valacyclovir Hcl | 90 | 31 |
| Sertraline Hcl | Sertraline Hcl | 89 | 28 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 88 | 13 |
| Carvedilol | Carvedilol | 86 | 23 |
| Lorazepam | Lorazepam | 86 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 86 | 21 |
| Raloxifene Hcl | Raloxifene Hcl | 86 | 20 |
| Tramadol Hcl | Tramadol Hcl | 85 | 18 |
| Glimepiride | Glimepiride | 83 | 18 |
| Metformin Hcl Er | Metformin Hcl | 83 | 28 |
| Vascepa | Icosapent Ethyl | 83 | 12 |
| Azelastine Hcl | Azelastine Hcl | 82 | 18 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 81 | 28 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 81 | 21 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 80 | 13 |
| Entresto | Sacubitril/Valsartan | 78 | 25 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 77 | 20 |
| Ozempic | Semaglutide | 76 | 16 |
| Potassium Chloride | Potassium Chloride | 71 | 26 |
| Bupropion Xl | Bupropion Hcl | 70 | 17 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 70 | 14 |
| Paxlovid | Nirmatrelvir/Ritonavir | 70 | 65 |
| Simvastatin | Simvastatin | 69 | 21 |
| Alendronate Sodium | Alendronate Sodium | 67 | 19 |
| Oxycodone Hcl | Oxycodone Hcl | 67 | 12 |
| Mirtazapine | Mirtazapine | 64 | 13 |
| Mounjaro | Tirzepatide | 64 | 15 |
| Telmisartan | Telmisartan | 63 | 15 |
| Hydrocortisone | Hydrocortisone | 62 | 17 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 62 | 16 |
| Ketoconazole | Ketoconazole | 61 | 19 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 60 | 55 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 59 | 15 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 58 | 11 |
| Nifedipine Er | Nifedipine | 58 | 15 |
| Spironolactone | Spironolactone | 58 | 15 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 57 | 11 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 57 | 19 |
| Chlorthalidone | Chlorthalidone | 57 | 12 |
| Levemir Flexpen | Insulin Detemir | 56 | suppressed |
| Latanoprost | Latanoprost | 55 | 13 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 55 | 17 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 52 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 51 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 48 | 22 |
| Atenolol | Atenolol | 45 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 45 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 43 | 39 |
| Fluoxetine Hcl | Fluoxetine Hcl | 43 | 11 |
| Labetalol Hcl | Labetalol Hcl | 42 | 14 |
| Levofloxacin | Levofloxacin | 42 | 33 |
| Nebivolol Hcl | Nebivolol Hcl | 42 | 12 |
| Donepezil Hcl | Donepezil Hcl | 41 | 12 |
| Cefuroxime | Cefuroxime Axetil | 40 | 33 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 40 | suppressed |
| Mupirocin | Mupirocin | 39 | 13 |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 39 | suppressed |
| Xarelto | Rivaroxaban | 39 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | 13 |
| Colchicine | Colchicine | 37 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 37 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 37 | 14 |
| Folic Acid | Folic Acid | 36 | suppressed |
| Metronidazole | Metronidazole | 36 | 28 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 35 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 35 | 12 |
| Clotrimazole | Clotrimazole | 35 | suppressed |
| Levetiracetam | Levetiracetam | 35 | suppressed |
| Celecoxib | Celecoxib | 34 | suppressed |
| Diazepam | Diazepam | 34 | 11 |
| Enalapril Maleate | Enalapril Maleate | 34 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 34 | 13 |
| Meclizine Hcl | Meclizine Hcl | 34 | 13 |
| Mometasone Furoate | Mometasone Furoate | 34 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 34 | 12 |
| Propranolol Hcl | Propranolol Hcl | 33 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 32 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 32 | 14 |
| Lidocaine | Lidocaine | 32 | suppressed |
| Cephalexin | Cephalexin | 31 | 23 |
| Dutasteride | Dutasteride | 31 | 13 |
| Ibuprofen | Ibuprofen | 31 | 15 |
| Risedronate Sodium | Risedronate Sodium | 31 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 29 | suppressed |
| Klor-Con M20 | Potassium Chloride | 29 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 23 |
| Creon | Lipase/Protease/Amylase | 28 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 28 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Clonidine | Clonidine | 27 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 27 | suppressed |
| Modafinil | Modafinil | 27 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 26 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 25 | suppressed |
| Fluconazole | Fluconazole | 25 | 21 |
| Estradiol | Estradiol | 24 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 24 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | suppressed |
| Glipizide Er | Glipizide | 22 | suppressed |
| Klor-Con M10 | Potassium Chloride | 22 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 22 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 21 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Methylprednisolone | Methylprednisolone | 20 | 14 |
| Single Use Swab | Alcohol Antiseptic Pads | 20 | suppressed |
| Fasenra Pen | Benralizumab | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 19 | suppressed |
| Myrbetriq | Mirabegron | 19 | suppressed |
| Novolog Flexpen | Insulin Aspart | 19 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 15 |
| Aripiprazole | Aripiprazole | 18 | suppressed |
| Clobetasol Emollient | Clobetasol Propionate/Emoll | 18 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 18 | suppressed |
| Lamotrigine | Lamotrigine | 18 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 18 | suppressed |
| Prolia | Denosumab | 18 | 12 |
| Warfarin Sodium | Warfarin Sodium | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 17 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 17 | suppressed |
| Calcitriol | Calcitriol | 16 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 16 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 16 | suppressed |
| Epinephrine | Epinephrine | 16 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 16 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 15 | suppressed |
| Ambien | Zolpidem Tartrate | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 15 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 15 | suppressed |
| Erythromycin | Erythromycin Base | 15 | suppressed |
| Minoxidil | Minoxidil | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 15 | suppressed |
| Vemlidy | Tenofovir Alafenamide | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 14 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 14 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 14 | suppressed |
| Restasis | Cyclosporine | 14 | suppressed |
| Zaleplon | Zaleplon | 14 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 13 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 13 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Rinvoq | Upadacitinib | 13 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 13 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Armodafinil | Armodafinil | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Proctozone-Hc | Hydrocortisone | 12 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 12 | suppressed |
| Tacrolimus | Tacrolimus | 12 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 12 | suppressed |
| Uloric | Febuxostat | 12 | suppressed |
| Acarbose | Acarbose | 11 | suppressed |
| Codeine Sulfate | Codeine Sulfate | 11 | suppressed |
| Memantine Hcl | Memantine Hcl | 11 | suppressed |
| Premarin | Estrogens, Conjugated | 11 | suppressed |
| Repaglinide | Repaglinide | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
| Tezspire | Tezepelumab-Ekko | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $180.54 · 8 records | ABBVIE INC. | CREON, LINZESS, QULIPTA, SYNTHROID, TRELEGY ELLIPTA, UBRELVY, VERQUVO, VOQUEZNA | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Creon play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error